ARCHIVES

Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 1 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

NIH, Lasker Foundation Offer Clinical Research Opportunity

December 10, 2010

Pediatric CCP Controversy Splits Group Leaders; National Consortium Forms; NCAB to Watch Closely

January 14, 1983

NCI Bypass Budget Request For FY 1982Seeks $1.192 Billion; Would Fund 40% Of Competing R01s

May 23, 1980

Sharon Murphy To Head New Research Center in San Antonio

August 2, 2002

Funding Opportunities.

April 12, 2002

ACS Prostate Cancer Recommendations Move Forward

August 7, 1992